HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Onne Reerink Selected Research

Neoplasms (Cancer)

11/2020Efficacy of Dose-Escalated Chemoradiation on Complete Tumor Response in Patients with Locally Advanced Rectal Cancer (RECTAL-BOOST): A Phase 2 Randomized Controlled Trial.
2/2019MRI-based tumor inter-fraction motion statistics for rectal cancer boost radiotherapy.
6/2018Tumor volume regression during preoperative chemoradiotherapy for rectal cancer: a prospective observational study with weekly MRI.
2/2016Inter-observer agreement of MRI-based tumor delineation for preoperative radiotherapy boost in locally advanced rectal cancer.
1/2016Dynamic contrast-enhanced MRI for treatment response assessment in patients with oesophageal cancer receiving neoadjuvant chemoradiotherapy.
5/2015Diffusion-weighted magnetic resonance imaging for the prediction of pathologic response to neoadjuvant chemoradiotherapy in esophageal cancer.
2/2015RandomizEd controlled trial for pre-operAtive dose-escaLation BOOST in locally advanced rectal cancer (RECTAL BOOST study): study protocol for a randomized controlled trial.
5/2014MRI-based tumor motion characterization and gating schemes for radiation therapy of pancreatic cancer.
11/2012Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer, a randomized controlled trial (ROBOT trial).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Onne Reerink Research Topics

Disease

12Rectal Neoplasms (Rectal Cancer)
01/2023 - 03/2004
9Neoplasms (Cancer)
11/2020 - 11/2012
4Esophageal Neoplasms (Esophageal Cancer)
05/2015 - 08/2012
2Neoplasm Metastasis (Metastasis)
07/2022 - 01/2021
2Pancreatic Neoplasms (Pancreatic Cancer)
11/2018 - 05/2014
1Colorectal Neoplasms (Colorectal Cancer)
11/2020
1Hepatocellular Carcinoma (Hepatoma)
12/2017
1Pathologic Complete Response
05/2015
1Adenocarcinoma
01/2014
1Pain (Aches)
08/2012
1Vomiting
08/2012
1Deglutition Disorders (Dysphagia)
08/2012

Drug/Important Bio-Agent (IBA)

1Cetuximab (Erbitux)FDA Link
01/2014
1Phenobarbital (Luminal)FDA Link
08/2012
1Capecitabine (Xeloda)FDA Link
01/2005
1Fluorouracil (Carac)FDA LinkGeneric
01/2005
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2005

Therapy/Procedure

13Radiotherapy
07/2022 - 03/2004
5Neoadjuvant Therapy
01/2023 - 01/2015
2Organ Sparing Treatments
11/2020 - 06/2015
2Chemoradiotherapy
06/2018 - 03/2016
2Drug Therapy (Chemotherapy)
02/2015 - 01/2014
1Metastasectomy
07/2022
1Aftercare (After-Treatment)
05/2015
1Therapeutics
02/2015
1Esophagectomy
11/2012
1Palliative Care (Palliative Therapy)
08/2012
1Stents
08/2012
1Brachytherapy
08/2012
1Adjuvant Chemoradiotherapy
01/2005